Official Title
The Effect of Diabetes Mellitus on the Morbidity and Mortality Rates in Patients With COVID-19
Brief Summary

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be included in the study. The patients will be divided into two groups, as diabetics and non-diabetics. The COVID-19 patients' medical records will be evaluated and compared in terms of the duration of hospitalization, the presence of lung involvement in Computerised Tomography, the need for intensive care unit and mortality rates in patients with and without diabetes.

Detailed Description

All hospitalised patients with COVID-19 who have positive RT-PCR for SARS-COV-2 will be
included in the study.

The patients will be divided into two groups, as diabetics and non-diabetics. The diagnosis
of diabetes mellitus will be extracted from the medical records and medical history of the
patients hospitalised with COVID-19.

The COVID-19 patients medical records will be evaluated and compared in terms of the duration
of hospitalization, the presence of lung involvement in Computerised Tomography, the need for
intensive care unit and mortality rates in patients with and without diabetes.

Unknown status
COVID19
Diabetes Mellitus

Other: hospitalisation, necessity of ICU, mortality rate, lung involvement

hospitalisation, necessity of ICU, mortality rate, lung involvement

Eligibility Criteria

Inclusion Criteria:

- Patients hospitalized for COVID-19

Exclusion Criteria:

- Patients with known malignancy

- Pregnant patients

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: 80 Years
Countries
Turkey
Locations

Usak University Training and Research Hospital
Usak, Turkey

Investigator: Cevdet Duran
Contact: 02762212121
drcduran@gmail.com

Contacts

Cevdet Duran
02762212121
drcduran@gmail.com

Cevdet Duran, Principal Investigator
Uşak Üniversitesi Tıp fak

Uşak University
NCT Number
MeSH Terms
COVID-19
Diabetes Mellitus